INSTITUTE FOR IN VITRO SCIENCES INC

EIN: 522029668 501(c)(3) Education

GAITHERSBURG, MD

Total Revenue
$6,877,981
Total Expenses
$7,165,636
Total Assets
$6,152,852
Net Assets
$2,341,887
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1997
Legal Domicile
MD
Principal Officer
AMANDA K ULREY
Phone
3019476523
Tax Period
2023-01-01 to 2023-12-31

INSTITUTE FOR IN VITRO SCIENCES INC, founded in 1997, is a community nonprofit in the Education sector that reported $6.9M in total revenue in fiscal year 2023.

Mission

TO INCREASE THE USE AND ACCEPTANCE OF NON-ANIMAL TEST METHODS WORLDWIDE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $1,057,602
Program Service Revenue $5,815,193
Investment Income $5,121
Other Revenue $65
TOTAL REVENUE $6,877,981

Expense Breakdown

Grants Paid $0
Salaries & Benefits $4,503,165
Fundraising Expenses $46,233
Program Expenses $6,637,279
Other Expenses $2,662,471
TOTAL EXPENSES $7,165,636

Year-over-Year Comparison

2023 2022 Change
Revenue $6,877,981 $6,860,766 +0.0%
Expenses $7,165,636 $6,922,486 +0.0%
Net Income $-287,655 $-61,720 +3.7%
Key Indicators
✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
8
Independent Members
5
Employees
54
Volunteers
5

Governance Policies

✓ Conflict of Interest Policy
✓ Whistleblower Policy
✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
4
$392,109
Total Directors
9
$392,109
Key Employees
0
$0
Highest Compensated
5
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
JOHN R FOWLE DIRECTOR 0.50
Director
$0 $0 $0
JAMES M HOFFMAN DIRECTOR 0.50
Director
$0 $0 $0
RICHARD E KOURI DIRECTOR 0.50
Director
$0 $0 $0
A WALLACE HAYES DIRECTOR 0.50
Director
$0 $0 $0
DANIEL A BAGLEY DIRECTOR 0.50
Director
$0 $0 $0
RODGER D CURREN CEO/BOARD CHAIR/SECRETARY 10.00
Officer Director
$51,077 $1,071 $52,148
AMANDA K ULREY PRESIDENT/BOARD MEMBER 40.00
Officer Director
$138,367 $6,590 $144,957
HANS A RAABE CHIEF OPERATING OFFICER/TREASURER 40.00
Officer Director
$153,112 $25,023 $178,135
ERIN H HILL PRESIDENT/BOARD MBR. (THRU 1/2023) 40.00
Officer Director
$15,575 $1,294 $16,869
GERTRUDE-EMILIA COSTIN DIRECTOR OF LABORATORY SERVICES 40.00
Highest
$145,496 $23,064 $168,560
HOLGER P BEHRSING DIRECTOR RESPIRATORY TOXICOLOGY 40.00
Highest
$156,494 $14,731 $171,225
BRENT J GILBERT DIRECTOR, BUSINESS DEVELOPMENT 40.00
Highest
$142,627 $25,692 $168,319
QUANSHUN ZHANG SENIOR SCIENTIST & PROJECT LEADER 40.00
Highest
$106,201 $28,231 $134,432
NATHAN R WILT STUDY DIRECTOR 40.00
Highest
$114,995 $16,432 $131,427
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 No data No data No data No data
2023 $6,877,981 $7,165,636 $6,152,852 $-287,655
2022 $6,860,766 $6,922,486 $6,566,155 $-61,720
2021 $6,503,470 $6,070,350 $4,102,375 $433,120
2020 $5,879,153 $5,698,595 $4,281,216 $180,558
2019 $5,519,690 $5,897,856 $3,490,495 $-378,166
2018 $5,484,946 $5,192,081 $2,966,766 $292,865
Explore More Nonprofits
→Top 100 Nonprofits in Maryland →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare INSTITUTE FOR IN VITRO SCIENCES INC with other nonprofits in Maryland and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.